The Effect of LUTS/BPH and Treatments on Ejaculatory Function.
As men age, there is an increased incidence of lower urinary tract symptoms (LUTS), often from benign prostatic hyperplasia (BPH) which can adversely affect sexual function. There are many different treatments for these symptoms; however, many of the treatments also affect sexual quality of life, specifically in the realm of ejaculation. Our paper will review the medications, surgical procedures, minimally invasive procedures, and even investigational procedures used to treat LUTS/BPH and the effect they have on ejaculation. The aim of this paper is to help practitioners counsel patients more effectively on treatment options when ejaculation is a concern.
Division of Urology, Southern Illinois University School of Medicine, 301 N 8th St-4th Floor, PO Box 19665, Springfield, IL, 62794-9665, USA.
Michelle
M
Herberts
Park Nicollet Urology, Minneapolis, MN, USA.
Michael
M
Butcher
Division of Urology, Southern Illinois University School of Medicine, 301 N 8th St-4th Floor, PO Box 19665, Springfield, IL, 62794-9665, USA. tkohler@siumed.edu.
Tobias
T
Köhler
D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use; D058667:Adrenergic beta-3 Receptor Agonists / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D004542:Ejaculation / Q000502:physiology*; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000503:physiopathology* / Q000628:therapy; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000503:physiopathology* / Q000628:therapy; D011788:Quality of Life; D012735:Sexual Dysfunction, Physiological / Q000503:physiopathology / Q000628:therapy*; D013521:Urologic Surgical Procedures, Male
D058891:5-alpha Reductase Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D058667:Adrenergic beta-3 Receptor Agonists; D018680:Cholinergic Antagonists; D010726:Phosphodiesterase Inhibitors
5 AR inhibitors; AR blockers; Ejaculatory dysfunction; LUTS/BPH; PDE inhibitors; Sexual dysfunction